The American Chamber of Commerce in Bulgaria (www.amcham.bg) unites over 340 American, Bulgarian, and multinational companies operating in the country. For its 20 years the Chamber has become a leading business organization by initiating events covering topics in the following areas: economy, international and national policies, and social sphere.
The AmCham’s mission is to improve the business environment, investment climate, and living standards in the country by advocating to all stakeholders – government, business, NGO-s, and media – for productive dialogue and partnership.
AmCham Bulgaria is an affiliate of the U.S. Chamber of Commerce and a member of the European Council of American Chambers of Commerce (AmChams in Europe).
Contact:
Address: Sofia, Mladost-4, Biznes Park – Sofia, Sgrada 2, Et. 6, Bulgaria
Tel. +359 2 974 2743
Website: https://amcham.bg/
Krassimira Chemishanska, president of AmCham Bulgaria, highlights the opportunities Bulgaria can offer to foreign companies as well as investors and explains the fundamental role of collaboration in the country in…
Sasho Ganov, general manager at BB–NCIPD (BulBio), explains the role of the company in the national health system as the only state-owned enterprise in Bulgaria as well as shares his…
Nikolaos Xydias, general manager at GSK Bulgaria, explains the commitment of GSK to cutting-edge medicines and vaccines targeting respiratory diseases and HIV and highlights the reasons why pharmaceutical multinationals should…
Gergana Semova and Petko Konakchiev, founders of PharmDedict, share an overview of the Bulgarian regulatory dynamism, the reasons why healthcare companies should continue investing in the country, and explain why…
Nikolay Hadjidontchev, general manager at Actavis EAD – a Teva company (the sales and marketing part of the company) in Bulgaria, explains the importance of finding the right balance between…
Illiana Paunova is the first Executive Director and one of the founders of the Bulgarian Medicines Verification Organization (BgMVO), an organization which has been set up to fight against the…
Olia Vassileva, executive director at the Bulgarian Association of Pharmaceutical Wholesalers (BAPW), gives a clear explanation of the challenges facing wholesalers in Bulgaria, its current as well as future role…
Dr. Hristo Trunchev, country president at Novartis Bulgaria and president of the Association of Research-Based Pharmaceutical Manufacturers in Bulgaria (ARPharM), shares an overview of the business scenario for research-based pharmaceutical…
Metodija Chadikovski, general manager at Roche Bulgaria, explains the importance of conducting high quality diagnostics to successfully target the right drug to the right patient as well as the affiliate’s…
Krassimira Chemishanska, country director at Amgen Bulgaria, showcases the role of innovative players in the country, the importance of moving towards a value-based assessment system, and how Amgen has performed…
Urszula Orzel, general manager at MSD Bulgaria, explains how the affiliate has become one of the fastest growing players in the country and emphasizes that pharmaceutical companies are not merely…
Prof. Dr. Kamen Plochev, Dr. M. Sc., recently appointed as the governor of the National Health Insurance Fund in Bulgaria, discusses the key issues he has identified for the Bulgarian…
Stanimir Hasurdjiev explains the key role of the National Patients’ Organization (NPO) in Bulgaria and discusses the main areas that he is working on to ensure that patients are heard…
See our Cookie Privacy Policy Here
